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phingosine-1-phosphate (S1P) is a bioactive sphingolipid
metabolite that regulates diverse biological processes
by binding to a family of G protein–coupled receptors
or as an intracellular second messenger. Mammalian S1P
phosphatase (SPP-1), which degrades S1P to terminate its
actions, was recently cloned based on homology to a lipid
phosphohydrolase that regulates the levels of phosphorylated
sphingoid bases in yeast. Confocal microscopy surprisingly
revealed that epitope-tagged SPP-1 is intracellular and
colocalized with the ER marker calnexin. Moreover, SPP-1
activity and protein appeared to be mainly enriched in the
intracellular membranes with lower expression in the
plasma membrane. Treatment of SPP-1 transfectants with
S1P markedly increased ceramide levels, predominantly
S
 
in the intracellular membranes, diminished survival, and
enhanced apoptosis. Remarkably, dihydro-S1P, although a
good substrate for SPP-1 in situ, did not cause signiﬁcant
ceramide accumulation or increase apoptosis. Ceramide
accumulation induced by S1P was completely blocked by
fumonisin B1, an inhibitor of ceramide synthase, but only
partially reduced by myriocin, an inhibitor of serine
palmitoyltransferase, the ﬁrst committed step in de novo
synthesis of ceramide. Furthermore, S1P, but not dihydro-S1P,
 
stimulated incorporation of [
 
3
 
H]palmitate, a substrate for
both serine palmitoyltransferase and ceramide synthase,
into C16-ceramide. Collectively, our results suggest that
SPP-1 functions in an unprecedented manner to regulate
sphingolipid biosynthesis and is poised to inﬂuence cell fate.
 
Introduction
 
Sphingosine-1-phosphate (S1P),* a bioactive lipid produced
from the metabolism of sphingolipids, regulates vital biological
processes (Pyne and Pyne, 2000; Spiegel and Milstien,
2000a, 2002; Hla et al., 2001). S1P is the ligand of a fam-
ily of specific cell surface G protein–coupled receptors
(GPCRs), hereafter referred to as S1PRs. These receptors,
which include EDG-1/S1P
 
1
 
, EDG-5/S1P
 
2
 
, EDG-3/S1P
 
3
 
,
EDG-6/S1P
 
4
 
, and EDG-8/S1P
 
5
 
, couple to various G proteins
to regulate cell migration, angiogenesis, vascular maturation,
heart development, and neurite retraction (Pyne and Pyne,
2000; Spiegel and Milstien, 2000a, 2002; Hla et al., 2001).
Sphinganine-1-phosphate (dihydro-S1P), which is identical
to S1P and only lacks the trans 4,5 double bond, binds to all
of the S1PRs and activates them, yet does not mimic all of
the effects of S1P, especially those related to cell survival and
protection against apoptosis (Van Brocklyn et al., 1998; Xia
et al., 1998; Morita et al., 2000; Rosenfeldt et al., 2001).
This led to the suggestion that S1P may have novel dual
functions, acting not only as an extracellular mediator but
possibly intracellularly through, as yet, unidentified targets
(Spiegel and Milstien, 2002).
Many external stimuli, particularly growth and survival
factors, activate sphingosine kinase, which phosphorylates
sphingosine and increases cellular S1P levels. Intracellularly
generated S1P can mobilize calcium from internal stores
(Mattie et al., 1994; Meyer zu Heringdorf et al., 1998),
suppress ceramide-mediated apoptosis (Cuvillier et al., 1996;
Morita et al., 2000), or can act in a paracrine or autocrine
fashion to activate S1P
 
1
 
 signaling, which is crucial for directed
cell movement (Hobson et al., 2001). Thus, due to the pivotal
role of S1P in regulating cellular processes, it is not surprising
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that its levels are low and tightly regulated in a spatial–temporal
manner through its synthesis catalyzed by sphingosine ki-
nase and degradation by an ER pyridoxal phosphate–depen-
dent S1P lyase and still not well-characterized phosphohy-
drolase activities.
As a first approach to identify specific mammalian S1P
phosphatases, two genes were cloned from 
 
Saccharomyces cere-
visiae
 
, 
 
LBP1/YSR2/LCB3
 
 and 
 
LBP2/YSR3,
 
 that encode spe-
cific sphingoid base phosphate phosphatases (Mao et al.,
1997; Qie et al., 1997; Mandala et al., 1998). These S1P
phosphatases belong to the family of magnesium-inde-
pendent, 
 
N
 
-ethylmaleimide–insensitive type 2 lipid phos-
phate phosphohydrolases (LPPs) (Stukey and Carman, 1997;
Brindley and Waggoner, 1998). However, except for their
conserved residues within three domains present in all LPPs
(Stukey and Carman, 1997), they have little overall homology
to other known LPPs. Genetic manipulations demonstrated
that these S1P phosphohydrolases regulate the levels of phos-
phorylated sphingoid bases and ceramide and influence
growth and survival of yeast after nutrient deprivation and
heat stress (Dickson et al., 1997; Jenkins et al., 1997; Man-
dala et al., 1998; Mao et al., 1999; Skrzypek et al., 1999).
On the basis of sequence homology with 
 
LBP1,
 
 the first
mammalian homologue, murine S1P phosphatase 1 (mSPP-
1), was recently cloned. This hydrophobic enzyme contains
430 amino acids, 8–10 membrane-spanning regions, and de-
grades S1P, but not lysophosphatidic acid (LPA), a structur-
ally related lysophospholipid (Mandala et al., 2000). By con-
trast, the other LPPs have broad substrate specificities and
degrade LPA, phosphatidic acid (PA), diacylglycerolpyrophos-
phate, S1P, and ceramide-1-phosphate (Brindley and Wag-
goner, 1998). Previous studies have demonstrated that LPP1
is localized on the plasma membrane, with an externally ori-
ented catalytic site, and functions as an ectophosphatase to
attenuate the actions of LPA as an agonist of its cell surface
receptors (Jasinska et al., 1999). However, more recently, it
has been shown that the ability of LPP1 and LPP2 to attenu-
ate GPCR signaling correlates with reduced intracellular PA
and not with ectolipid phosphate phosphatase activity (Alder-
ton et al., 2001). Moreover, although LPA-induced mitogen-
esis is regulated by LPPs, in an analogous manner to the in-
tracellular actions of S1P (Van Brocklyn et al., 1998), it is
also LPA receptor independent (Hooks et al., 2001). Thus,
we examined the subcellular localization of SPP-1 in order to
define its biological function and to determine whether it
might play a role in regulating extracellular or intracellular
levels of S1P. The results of this study indicate that this novel
lipid phosphohydrolase is located mainly in the ER and that
it functions in an unprecedented manner to regulate biosyn-
thesis of ceramide, which plays a critical role in apoptosis.
 
Results
 
mSPP-1 activity is membrane associated
 
Overexpression of mSPP-1 in human embryonic kidney
(HEK) 293 cells, either transiently or stably, resulted in mark-
edly increased S1P phosphohydrolase activity (Fig. 1 A), in
agreement with previous studies (Le Stunff et al., 2002). This
activity was almost exclusively membrane associated and the
presence of the Myc epitope tag did not significantly alter the
activity (Fig. 1 A). Western blot analysis with an anti-Myc
mAb also revealed that mSPP-1 was only expressed in the
membrane fraction (Fig. 1 B). Similar results were obtained in
NIH 3T3 fibroblasts (unpublished data). Furthermore, fluo-
rescence microscopy revealed a diffuse intracellular distribu-
tion of Myc-tagged mSPP-1 in these cells (Fig. 1 C).
 
Subcellular localization of mSPP-1
 
To better define the cellular localization of mSPP-1, we next
used confocal immunofluorescence microscopy. In NIH
3T3 fibroblasts, Myc–mSPP-1 was distributed in a perinu-
Figure 1. mSPP-1 activity is membrane associated in mammalian 
cells. (A) S1P phosphohydrolase activity was measured in 
membrane fractions from HEK 293 cells transiently and stably 
transfected with Myc-pcDNA3 (vector), mSPP-1–pcDNA3.1 (mSPP-1), 
or Myc-pcDNA–mSPP-1 (Myc–mSPP-1). S1P phosphohydrolase 
activity in cytosol fractions from these cells was  1 nmol/min/mg. 
Data are means   SEM of five independent experiments, each 
performed in duplicate. (B) Western blot showing expression of 
mSPP-1. Triton X-100 extract (lysate) and membrane and cytosolic 
fractions (50  g of proteins) from vector-transfected and Myc–
mSPP-1–transfected HEK 293 cells were resolved by SDS-PAGE and 
then immunoblotted with a monoclonal Myc antibody. The lower 
nonspecific band was detected in both vector and mSPP-1–transfected 
cells. (C) Cellular localization of Myc–mSPP-1. NIH 3T3 fibroblasts 
transiently expressing vector or Myc-pcDNA–mSPP-1 were incubated 
with a monoclonal Myc antibody, stained with anti–mouse Texas 
red monoclonal IgG, and visualized by fluorescence microscopy. 
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clear and reticular pattern, reminiscent of an ER localization
(Fig. 2). Indeed, there was no significant colocalization with
cortical actin, stained with fluorescent phalloidin, the Golgi
apparatus, stained with fluorescent WGA, or with Mi-
toTracker-stained mitochondria, as demonstrated by the ab-
sence of yellow color in the merged images (Fig. 2). On the
contrary, mSPP-1 expression was clearly colocalized with the
ER marker calnexin (Fig. 3 A). Identical results were found
with HEK 293 cells overexpressing Myc–mSPP-1 (Fig. 3 B),
demonstrating that the subcellular distribution was not cell
type specific. Thus, interestingly, in contrast to the well-
defined plasma membrane localization of LPP1 (Jasinska et al.,
1999; Zhang et al., 2000), mSPP-1 appeared to be expressed
on intracellular membranes.
Because LPP1 has been shown to have substantial ecto-
phosphatase activity by virtue of its plasma membrane local-
ization, it was of interest to also examine mSPP-1 activity in
subcellular fractions. mSPP-1–expressing HEK 293 cells
were subcellularly fractionated by differential centrifugation
into P1, P2, and cytosol fractions. Specific enzyme markers
were used to substantiate and define purity of the different
compartments (Fig. 4 A). The P1 fraction contained intra-
cellular organelles, as indicated by the presence of both cyto-
chrome C oxidase II and phosphodisulfide isomerase, spe-
cific markers of the mitochondria and ER, respectively.
Plasma membranes were associated with P2 as indicated by
the expression of 
 
 
 
v
 
-integrin. mSPP-1 expression appeared
to be enriched in the P1 intracellular membranes fraction
(Fig. 4 A), in agreement with the ER localization shown by
confocal microscopy. Very low levels of mSPP-1 expression
were also detected in the P2 plasma membrane fraction. In
concordance with the expression pattern of the protein, the
majority of S1P phosphohydrolase activity was detected in
P1, with much lower amounts in the P2 fraction (Fig. 4 B).
Figure 2. mSPP-1 does not colocalize 
with the actin network, Golgi apparatus, 
or mitochondria. NIH 3T3 fibroblasts 
were transiently transfected with Myc–
mSPP-1 and visualized by confocal 
fluorescence microscopy in the left panels 
after staining for cortical actin (A), Golgi 
network (B), or mitochondria (C) with 
Alexa Fluor
®488–phalloidin, fluorescent 
WGA, or MitoTracker green, respectively. 
Center panels show the localization of 
mSPP-1 in the same cells visualized 
with anti-Myc antibody and Texas red–
conjugated secondary antibody. Right 
panels show the superimposed pictures.
Figure 3. mSPP-1 is localized to the 
ER. NIH 3T3 fibroblasts (A) and HEK 293 
cells (B) were transiently transfected 
with Myc–mSPP-1, and stained for ER 
using anti-calnexin antibody (left panels) 
and for mSPP-1 using anti-Myc antibody 
(center panels). Cells were visualized by 
dual wavelength confocal microscopy. 
Right panels show the superimposed 
merged pictures, yellow color indicating 
colocalization. 
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Moreover, although mSPP-1–transfected cells had fivefold
and threefold higher S1P phosphohydrolase activity in the
P1 and P2 fractions, respectively, compared with the vector
transfectants, the total activity in the P1 fraction was much
greater, and mSPP-1 expression and activity were not de-
tected in the cytosolic fraction (Fig. 4 B).
 
Overexpression of mSPP-1 modulates ceramide levels
 
mSPP-1 is a highly specific sphingoid base phosphate phos-
phohydrolase (Mandala et al., 2000). In agreement with re-
cent results in CHO and HEK 293 cells (Le Stunff et al.,
2002), both S1P and dihydro-S1P, which has an identical
structure except lacks the trans 4,5 double bond, are hydro-
lyzed similarly by mSPP-1 (Fig. 5 A). Moreover, the addi-
tion of unlabeled S1P and dihydro-S1P decreased hydrolysis
of [
 
32
 
P]S1P in a dose-dependent manner, although S1P was
more effective than dihydro-S1P (Fig. 5 B).
Because both S1P and dihyro-S1P are substrates for
mSPP-1 in vitro (Fig. 5), and the products sphingosine and
dihydrosphingosine can be further metabolized by cells to
ceramide and dihydroceramide, respectively, it was of inter-
est to determine whether overexpression of mSPP-1 altered
sphingolipid metabolism. When empty vector transfectants
were incubated with either S1P or dihydro-S1P, there were
no significant changes in ceramide levels (Fig. 6 A). How-
ever, treatment of mSPP-1–overexpressing cells with S1P,
but surprisingly not with dihydro-S1P, resulted in a more
than twofold increase in ceramide (Fig. 6 A). In apparent
agreement with the localization of mSPP-1, most of the in-
crease in ceramide after S1P treatment occurred in the inter-
nal membrane fraction, although there also was a small in-
crease of ceramide in the plasma membrane fraction (Fig. 6
B). Not surprisingly, because the majority of ceramide is
membrane associated, no changes in cytosolic ceramide lev-
els were detected. Thus, it is most likely that as a conse-
quence of overexpression of mSPP-1, the increased sphingo-
sine generated by dephosphorylation of exogenous S1P has
been diverted to ceramide generation by ceramide synthase–
catalyzed N-acylation of sphingosine.
 
Ceramide accumulation is associated with apoptosis
 
Ceramide has been implicated as a critical component of ap-
optosis (Kolesnick and Hannun, 1999; Hannun and Lu-
berto, 2000), whereas elevation of S1P has been shown to
play a cytoprotective role (Spiegel and Milstien, 2000b),
particularly in opposing ceramide-mediated apoptosis (Cu-
Figure 4. Subcellular fractionation of HEK 293 cells transfected 
with Myc–mSPP-1. (A) Lysates from HEK 293 cells stably transfected 
with vector or Myc–mSPP-1–pcDNA3 were subcellularly fractionated 
into P1 (intracellular membrane fraction containing mitochondria, 
ER, and Golgi), P2 (plasma membrane), and cytosol, as described in 
the Materials and methods. Proteins (25  g) were resolved by 
SDS-PAGE and immunoblotted with anti-Myc, anti–cytochrome C 
oxidase, anti-PDI, or anti– v-integrin as specific organelle markers. 
Similar results were obtained in two additional experiments. (B) S1P 
phosphohydrolase activity was determined in each subcellular 
fraction using [
32P]S1P (10  M) as substrate. Results are means   SD 
of three different preparations.
Figure 5. S1P and dihydro-S1P are substrates of 
mSPP-1. (A) S1P phosphohydrolase activity was 
measured in membrane fractions from HEK 293 
cells stably transfected with vector (open bars) or 
mSPP-1 (filled bars) with 10  M 
32P-labeled S1P or 
dihydro-S1P as substrates. (B) Effect of unlabeled 
S1P and dihydro-S1P on hydrolysis of [
32P]S1P. 
Membrane fractions from the transfected cells 
were incubated with 1  M [
32P]S1P for 30 min at 
37 C in the presence of increasing concentrations 
of unlabeled S1P or dihydro-S1P, and 
32Pi release 
was measured. Results are the means   SEM of 
three different experiments, each performed in 
duplicate. 
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villier et al., 1996; Morita et al., 2000). Thus, we examined
whether ceramide accumulation correlated with the induc-
tion of apoptosis. Similar to our results with NIH 3T3 fi-
 
broblasts transiently transfected with mSPP-1 (Mandala et
al., 1998), treatment of HEK 293 cells stably expressing
mSPP-1 with 5 
 
 
 
M S1P not only resulted in ceramide ele-
vation (Fig. 6), it also markedly induced apoptosis (Fig. 7).
By contrast, treatment with dihydro-S1P, which did not in-
crease ceramide levels, had no significant effect on apoptosis.
 
Ceramide biosynthesis: the role of ceramide synthase
 
As S1P treatment increased ceramide levels, resulting in apop-
tosis, it was important to determine the source of this cer-
amide. Similar to previous studies (Kroesen et al., 2001),
TLC resolved ceramide (after derivatization into ceramide
phosphate) into two bands; long and very long chain cer-
amides migrate with the lower and upper bands, respectively
(Kroesen et al., 2001). We noticed that after S1P addition to
SPP-1–expressing cells, there was a marked increase in the
lower band (Fig. 8 A). Indeed, when SPP-1 transfectants
were labeled with [
 
3
 
H]palmitate, which serves as a substrate
for both serine palmitoyltransferase and ceramide synthase,
S1P induced a 3.8-fold increase in the incorporation of ra-
dioactivity into the lower ceramide band (Fig. 8 B), which
comigrated with C16-ceramide. When cells were labeled
with 
 
L
 
-3-[
 
3
 
H]serine, a substrate for serine palmitoyltrans-
ferase, radioactive serine was incorporated predominantly
into the upper ceramide band (Fig. 8, C and D). Surpris-
ingly, S1P inhibited incorporation of serine into the upper
ceramide band but increased incorporation into the lower
ceramide band in mSPP-1 transfectants (Fig. 8, C and D).
To examine the pathways involved in the generation of
long chain ceramide, we used two inhibitors of de novo syn-
thesis of ceramide: myriocin (ISP-1), a specific inhibitor of
serine palmitoyltransferase; and fumonisin B1 (FB1), an in-
hibitor of CoA-dependent dihydroceramide/ceramide syn-
thase. As expected, ISP-1 completely blocked [
 
3
 
H]serine in-
corporation into the ceramides (Fig. 8 D). However, ISP-1
only reduced the incorporation of labeled palmitic acid into
C16-ceramide and ceramide accumulation induced by S1P
in mSPP-1 transfectants by 30% (Fig. 8, E and F). ISP-1
also had no influence on the inability of dihydro-S1P to in-
crease ceramide levels (unpublished data).
In contrast to ISP-1, FB1 completely prevented the in-
crease in intracellular ceramide levels resulting from treat-
Figure 6. S1P, but not dihydro-S1P, increases ceramide levels in 
cells overexpressing mSPP-1. (A) Vector-transfected or mSPP-1–
expressing HEK 293 cells were incubated in the absence (None) or 
presence of 5  M dihydro-S1P or S1P for 48 h. Ceramide levels 
were then determined as described in the Materials and methods. 
(B) Ceramide levels are elevated predominantly in internal membranes. 
Lysates were prepared from cells treated with S1P, as described in 
Fig. 4 A, and ceramide levels in the indicated subcellular fractions 
(P1, P2, and cytosol) were determined. Data are the means   SEM of 
three independent experiments, each performed in duplicate.
Figure 7. S1P, but not dihydro-S1P, 
induces apoptosis in cells overexpressing 
mSPP-1. (A) HEK 293 cells stably 
transfected with vector or mSPP-1 were 
incubated in the absence or the presence 
of 5  M S1P or dihydro-S1P for 3 d. Note 
the typical condensed fragmented nuclei 
of apoptotic cells in mSPP-1 transfectants 
treated with S1P but not with dihydro-S1P. 
(B) Percentages of apoptotic cells over-
expressing SPP-1 were determined by 
fluorescence microscopy as described in 
the Materials and methods. Apoptotic 
cells displaying fragmented nuclei 
indicative of apoptosis were counted 
and a minimum of 500 cells in each 
field was scored. Data are means   SEM 
of three independent experiments, each 
performed in duplicate. 
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ment of mSPP-1–expressing cells with S1P and did not affect
the low levels of ceramide in dihydro-S1P–treated cells (Fig.
9 A). In agreement, there was a concomitant large increase in
sphingosine levels (Fig. 9 B). These results indicate that the
recombinant mSPP-1 was indeed active in vivo, converting
S1P to sphingosine that was then readily metabolized to
ceramide via ceramide synthase. Remarkably, although no
changes in the levels of ceramides could be detected when
mSPP-1–expressing cells were treated with dihydro-S1P,
when added in the presence of FB1, there was a large accu-
mulation of dihydrosphingosine (Fig. 9 B). These results
confirm that dihydro-S1P is indeed cleaved by mSPP-1 intra-
cellularly, yet there is no accompanying accumulation of
ceramide, suggesting rapid metabolism of dihydroceramide to
sphingomyelin or complex sphingolipids. Moreover, dihy-
dro-S1P, which has no effect on the survival of vector- or
mSPP-1–transfected cells, induces apoptosis of the mSPP-1
transfectants, but not vector cells, only when added in the
presence of FB1 (Fig. 9 B, inset). This is in agreement with
previous studies showing that the accumulation of long chain
sphingoid bases causes apoptosis (Sakakura et al., 1998; Perry
et al., 2000; Cuvillier et al., 2001; Kagedal et al., 2001). It
should be noted that FB1 caused a large increase in basal
sphingosine levels in mSPP-1 compared with vector trans-
fectants (Fig. 9 B). This result suggests that normal turnover
of intracellular S1P is a dynamic process that can contribute
to the regulation of ceramide levels.
The (R,R)-(
 
D
 
-threo) isomer of 1-phenyl-2-decanoylamino-
3-morpholino-1-propanol (PDMP), an analogue of gluco-
sylceramide and a potent inhibitor of glucosylceramide syn-
thase (Shayman et al., 2000), was used to examine whether
the increased ceramide in mSPP-1–expressing cells might
arise partly due to a lower rate of its conversion to gluco-
sylceramide and other complex glycosphingolipids. PDMP
 
at 10 
 
 
 
M, a concentration that potently inhibits gluco-
sylceramide synthase activity in vitro (Shayman et
al., 2000), increased ceramide by 2.5-fold over basal levels
in untreated and dihydro-S1P–treated mSPP-1–expressing
cells, and markedly augmented the elevated ceramide accu-
mulation induced by S1P (Fig. 10 A) without significantly
affecting sphingosine levels (Fig. 10 B). Thus, it is unlikely
that decreased utilization of ceramide for the formation of
glucosylceramide is responsible for its accumulation.
 
Discussion
 
mSPP-1 is localized to the ER
 
The bioactive lipids S1P and LPA are both intracellular and
extracellular mediators. To better understand their func-
tions, it is important to determine how their levels are regu-
lated. Whereas much has been learned about the phos-
phatases that degrade LPA, less is known about degradation
of S1P. It has been suggested that LPPs function as ecto-
phosphohydrolases to degrade LPA and thus attenuate extra-
cellular cell signaling by decreasing the availability of this
GPCR agonist (Waggoner et al., 1999). We have now dem-
onstrated that SPP-1 resides predominantly in the ER both
by confocal microscopy and subcellular fractionation. Thus,
it is likely that SPP-1 is one of the enzymes responsible for
the regulation of the intracellular levels of S1P and dihydro-
S1P and, concomitantly, sphingosine and dihydrosphin-
gosine. Similarly, the yeast homologues of SPP-1, LBP1/
YSR2/LCB3 and LBP2/YSR3, are also located in the ER
(Mao et al., 1999). Because the ER contains the other en-
zymes of ceramide biosynthesis, localization of SPP-1 to this
compartment suggests that it could play an important role in
the regulation of sphingolipid metabolism, particularly cer-
amide biosynthesis.
Figure 8. S1P, but not dihydro-S1P, induces 
biosynthesis of ceramide in mSPP-1–transfected 
cells. (A) Vector- and mSPP-1–transfected HEK 293 
cells were incubated for 24 h without or with 5  M 
S1P or 5  M dihydro-S1P and ceramide determined 
after phosphorylation to ceramide-1-phosphate 
(C1P) in the DAG kinase assay. The upper and lower 
C1P bands are derived from very long and long 
chain ceramides, respectively. (B) Duplicate cultures 
were incubated with [
3H]palmitic acid (10  Ci/ml), 
ceramide isolated, separated by TLC, and then 
visualized by autoradiography. (C) Similarly, 
labeled ceramide from cells incubated with 
L-3-[
3H]serine (30  Ci/ml) was isolated, separated 
by TLC, and two ceramide bands were radioactivity 
quantitated with a radiochromatogram scanner 
(open bars, long chain ceramide; filled bars, very 
long chain ceramide). (D–F) Effect of ISP-1. Cells 
were incubated without or with 5  M S1P in the 
absence or presence of 10  M ISP-1 and labeled 
with L-[
3H]serine (D) or [
3H]palmitic acid (E). 24 h 
later, lipids were separated by TLC. Ceramide mass 
was measured in unlabeled duplicate cultures (F). 
Data are means   SEM of three experiments, 
each performed in duplicate. For all panels, a 
representative result from three independent 
experiments is shown. 
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SPP-1 regulates ceramide levels
 
Ceramide biosynthesis at the cytoplasmic face of the ER is
initiated by condensation of 
 
L
 
-serine with palmitoyl CoA,
catalyzed by serine palmitoyltransferase (Futerman et al.,
1990; Merrill et al., 1993). In two rapid reactions, the prod-
uct, 3-ketosphinganine, is reduced to sphinganine (dihy-
drosphingosine) and subsequently acylated by ceramide syn-
thase to form dihydroceramide (Fig. 11). Dihydroceramide
is then converted to ceramide by a desaturase (Michel and
van Echten-Deckert, 1997). Ceramide, or in some cases, di-
hydroceramide, is translocated from the ER to the Golgi
apparatus by not well-defined mechanisms, and then con-
verted to sphingomyelin by the enzyme phosphatidylcholine:
ceramide cholinephosphotransferase (sphingomyelin synthase)
on the lumenal side of the Golgi apparatus or to glucosyl-
ceramide on the cytosolic surface of the Golgi apparatus (for
reviews see van Meer and Holthuis, 2000; Funato and Riez-
man, 2001). After translocation into the Golgi lumen, gluco-
sylceramide is further converted to lactosylceramide and
more complex glycosphingolipids.
In line with a significant role for SPP-1 in regulating the
balance of sphingolipid metabolites, we found that overex-
pressing SPP-1 in mammalian cells increased ceramide lev-
els, particularly in the presence of exogenous S1P. Similarly,
yeast overexpressing 
 
LBP1
 
 accumulate ceramide and, con-
versely, deletion of 
 
LBP1
 
 results in the accumulation of
phosphorylated long chain sphingoid bases and reduced cer-
amide levels (Mao et al., 1997, 1999; Mandala et al., 1998).
Surprisingly, however, dihydro-S1P, which is also readily
dephosphorylated by SPP-1 in situ, did not cause an eleva-
tion of ceramide levels. Yet, FB1, an inhibitor of ceramide
Figure 9. Fumonisin B1 prevents ceramide elevation induced by 
S1P in mSPP-1 transfectants. Vector- or mSPP-1–transfected HEK 
293 cells were treated with 5  M S1P or dihydro-S1P in the absence 
or presence of 25  M fumonisin B1 for 48 h as indicated. Ceramide 
(A) and sphingosine levels (B) were determined as described in the 
Materials and methods. Sphingosine levels in vector and mSPP-1 
transfectants treated with vehicle, S1P, or dihydro-S1P were 0.1   0.02 
and 0.2   0.02, 0.9   0.3 and 1.1   0.3, 1   0.4 and 1   0.4 
pmol/nmol phospholipid, respectively. Data are the means   SEM 
of three independent experiments, each performed in duplicate.
(Inset) mSPP-1–transfected HEK 293 cells were treated with vehicle, 
S1P (5  M), or dihydro-S1P (5  M) in the absence ( ) or presence 
( ) of 25  M fumonisin B1 for 48 h. Percentages of apoptotic cells 
were determined by Hoechst staining. A minimum of 500 cells in 
each field was scored.
Figure 10. PDMP enhances ceramide production induced by S1P 
in mSPP-1 transfectants. Vector- or mSPP-1–transfected HEK 293 
cells were incubated without or with 5  M S1P or dihydro-S1P in 
the absence or presence of 10  M PDMP as indicated. 24 h later, 
ceramide (A) and sphingosine (B) levels were determined. Data are 
means   SD of three independent experiments, each performed in 
duplicate. 
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synthase, induced accumulation of sphingoid bases when
cells were treated with either S1P or dihydro-S1P, suggest-
ing that the sphingosine and sphinganine produced in these
cells are indeed substrates for ceramide synthase. So why
does ceramide and not dihydroceramide accumulate and
what is the source of this ceramide?
ISP-1, an inhibitor of serine palmitoyltransferase, slightly
reduced the elevation of ceramide levels, suggesting that the
de novo pathway is not a major contributor. Moreover, both
S1P and dihydro-S1P decreased [
 
3
 
H]serine incorporation
into very long chain ceramides, whereas only S1P enhanced
incorporation into long chain ceramides that comigrated
with C16-ceramide. In agreement, S1P, and not dihydro-
S1P, also increased the incorporation of [
 
3
 
H]palmitate into
long chain ceramides. In addition, it appears that there is
not a major defect in the transport of ceramide from its site
of production at the ER to the Golgi apparatus, the site of
synthesis of glycosphingolipids, because PDMP, an inhibi-
tor of glucosylceramide synthase, enhanced ceramide levels
induced by S1P. Collectively, our data suggest that the pres-
ence or absence of the trans double bond in the sphingoid
bases dictates their function in the biosynthesis of ceramide.
 
Why does S1P, and not dihydro-S1P, 
regulate ceramide biosynthesis?
 
The generation of sphingosine, and not sphinganine, from
the hydrolysis of sphingolipids is a consequence of the consti-
tutive turnover of plasma membrane components through
the endocytic pathway. Even if a very small fraction of mem-
brane lipids are metabolized (Thilo, 1994), the absolute
amount of sphingosine generated would be quite large rela-
tive to the small intracellular pools. Although sphingosine is
solely a product of sphingolipid catabolism, it is also a sub-
strate for ceramide synthase (Merrill et al., 1993). In view of
the constitutive nature of the endocytic process/salvage path-
way, cells can conserve energy by reutilizing sphingosine,
minimizing the de novo synthesis of sphinganine. Indeed, it
has been shown that slowly dividing cells rely on this recy-
cling hydrolytic pathway for synthesis of the majority of gly-
cosphingolipids and sphingomyelin (Gillard et al., 1998).
Hence, sphingosine produced in late endosomes and lyso-
somes is phosphorylated on the cytosolic surface by sphingo-
sine kinase (Fig. 11) and S1P thus formed, due its more
hydrophilic nature, is readily transported to the ER and de-
phosphorylated by SPP-1 to sphingosine, where it is con-
verted to ceramide, predominantly N-palmitoyl-sphingosine.
It is tempting to speculate that S1P may play a critical role in
the downregulation of the de novo pathway by affecting
serine palmitoyltransferase or ceramide synthase (Fig. 11).
Thus, when the salvage pathway is active, sphingosine, and
concomitantly S1P, levels increase, leading to inhibition of
the de novo pathway. Ectopic expression of SPP-1 and deg-
radation of S1P results in the relief of this inhibition and,
concomitantly, formation of sphingosine, the substrate of cer-
amide synthase. In support of this provocative idea, suppression
of sphingoid base synthesis was observed after the addition of
lipoproteins or free sphingoid bases, as a consequence of the
downregulation of serine palmitoyltransferase by sphingoid
base-1-phosphates (van Echten-Deckert et al., 1997). More-
over, we and others have convincingly demonstrated that
mutations or deletions of LBP1, the yeast phosphatase, com-
pletely prevented the incorporation of exogenous dihy-
drosphingosine into sphingolipids (Mao et al., 1997; Qie et
al., 1997; Mandala et al., 1998; Zanolari et al., 2000). This
defect in sphingolipid synthesis supports the intriguing possi-
bility that externally supplied sphingoid bases are phosphory-
lated after their entry into the cell and require dephosphory-
lation before they can be used for ceramide biosynthesis
(Zanolari et al., 2000). Likewise, disruption of LCB4 and
LCB5, the genes encoding the sphingosine kinases in yeast,
markedly reduced the incorporation of exogenous dihy-
drosphingosine into sphingolipids (Zanolari et al., 2000).
SPP-1 and cell fate decisions
If S1P indeed plays a crucial role in regulating the key step
in biosynthesis of ceramide, this might be the explanation
Figure 11. Role of SPP-1 in biosynthesis 
and trafficking of sphingolipids and 
apoptosis. Scheme depicting the 
bioactive intermediates of sphingolipid 
biosynthesis. In brief, dihydroceramide 
and ceramide biosynthesis takes place at 
the cytosolic surface of the ER. In the 
membrane recycling/salvage pathway, 
sphingosine produced from sphingolipids 
in the lysosome is phosphorylated in the 
cytosol to S1P and dephosphorylated in 
the ER by SPP-1, where it is reutilized for 
synthesis of ceramide. Dihydroceramide 
and ceramide are transported to the 
cis-Golgi by vesicular transport, and 
nonvesicular transport to the TGN where 
they are converted to sphingomyelin 
and glucosylceramides. See text for 
more information.S1P phosphatase in sphingolipid metabolism and apoptosis | Le Stunff et al. 1047
for the opposing actions of S1P and ceramide on apoptosis
and why their dynamic balance is tightly coupled and con-
versely regulated. Whereas ceramide levels increase in re-
sponse to stress stimuli, suppression of apoptosis is associ-
ated with increases in S1P levels and decreases in ceramide
(for reviews see Hannun, 1996; Kolesnick and Hannun,
1999; Spiegel and Milstien, 2000b). Likewise, the balance
between the levels of ceramide and S1P, regulated by LBP1,
is also critical for survival and resistance to environmental
stress in yeast (Mao et al., 1997, 1999; Mandala et al.,
1998; Skrzypek et al., 1999), suggesting that the sphin-
golipid rheostat is an evolutionarily conserved stress regula-
tory mechanism.
Insertion of the trans 4,5 double bond into ceramide by
the desaturase is an important step because ceramide, and
not dihydroceramide, induces apoptosis (Hannun, 1996;
Kolesnick and Hannun, 1999; Scaffidi et al., 1999). Re-
markably, although dihydro-S1P is also a substrate for re-
combinant SPP-1 in situ, forming dihydrosphingosine (60
pmol/nmol phospholipid), which is then converted by an
FB1-sensitive ceramide synthase to dihydroceramide, our
finding that it did not accumulate suggests that dihydrocer-
amide may be more efficiently used for sphingomyelin and/or
glycosphingolipid biosynthesis than ceramide. Alternatively,
its translocation to the Golgi apparatus may be more rapid.
In this regard, whereas glucosylceramide synthase in the cis-
Golgi receives ceramide via vesicular transport, nonvesicular
transport from the ER to the Golgi apparatus has been de-
scribed in mammalian cells and yeast (Kok et al., 1998;
Funato and Riezman, 2001). Hence, ceramide, or more
likely, dihydroceramide, can be translocated from the ER to
the trans-Golgi via membrane contact sites to sphingomy-
elin and glucosylceramide synthases (Funato and Riezman,
2001). Thus, we are suggesting that ceramide and dihydro-
ceramide may have different biosynthetic trafficking and
that vesicular and nonvesicular pathways of ceramide versus
dihydroceramide transport may serve special functions (Fig.
11). Because membrane contact sites have often been ob-
served between the ER and mitochondria (Marsh et al.,
2001), it is also possible that these could be responsible for
the delivery of apoptotic ceramide, but not dihydrocer-
amide, to the mitochondria. Because dihydroceramides are
much less potent than ceramides in the induction of apopto-
sis (Hannun, 1996; Kolesnick and Hannun, 1999; Scaffidi
et al., 1999), our suggestion of divergence in the regulation
of ceramide and dihydroceramide synthesis has important
implications, not only for sphingolipid metabolism, but also
for their distinct roles in apoptosis.
Ceramide generation and apoptosis
Ceramide is now emerging as an important component of
mitochondrial-dependent apoptosis and in the regulation of
stress responses (Hannun, 1996; Kolesnick and Hannun,
1999; Scaffidi et al., 1999). Although it was originally pro-
posed that ceramide was generated from sphingomyelin by
the activation of one or more sphingomyelinases, a flurry of
recent studies have begun to implicate ceramide generated
from de novo sphingolipid biosynthesis in apoptosis (Bose et
al., 1995; Kolesnick and Hannun, 1999; Perry et al., 2000;
Kroesen et al., 2001). There is convincing evidence that
ceramide synthase as well as serine palmitoyltransferase are
activated during apoptosis (Bose et al., 1995; Perry et al.,
2000; Kroesen et al., 2001). In agreement, we found that
whereas S1P induced ceramide biosynthesis, particularly
C16-ceramide, and apoptosis in mSPP-1 transfectants, dihy-
dro-S1P had no effect on ceramide levels nor did it induce
apoptosis. Interestingly, induction of apoptosis through B
cell receptor cross-linking occurs via de novo–generated
C16-ceramide (Kroesen et al., 2001). In addition, in the
presence of FB1, both S1P and dihydro-S1P increased levels
of sphingoid bases and induced cell death. These results are
in concordance with several recent reports suggesting that
sphingoid bases are also apoptotic signaling molecules (Gudz
et al., 1997; Cuvillier et al., 2000; Kagedal et al., 2001).
Recent studies suggest a crucial role for de novo–gener-
ated C16-ceramide in mitochondrial damage leading to
downstream activation of caspases and apoptosis (Kroesen et
al., 2001). However, to date, how de novo–generated cer-
amide is transported from the ER to mitochondria is not
known, although as discussed above, close membrane con-
tact sites (Marsh et al., 2001) could be involved. Alterna-
tively, ceramide might be generated from sphingosine in mi-
tochondria via a mitochondrial ceramide synthase (Shimeno
et al., 1995). More recently, a novel mitochondrial cerami-
dase with reciprocal (ceramide synthase) activity that shows
strong preference for sphingosine over dihydrosphingosine
as substrate has been cloned (El Bawab et al., 2001). Thus,
sphingosine, but not sphinganine, formed at the ER by
mSPP-1 might be transported to the mitochondria and serve
as substrate for either of these ceramide synthase activities
(Fig. 11). This ceramide may induce apoptosis due to mito-
chondria damage, generation of reactive oxygen species, re-
lease of cytochrome C, and subsequent activation of caspase
activity. Interestingly, C16-ceramide, but not dihydrocer-
amide, can form stable channels in membranes that are large
enough to allow cytochrome C permeation and could be in-
volved in initiating mitochondrial-dependent apoptosis (Sis-
kind and Colombini, 2000). In agreement, elevation of en-
dogenous ceramide specifically in mitochondria, but not in
other subcellular compartments, resulted in the induction of
apoptosis (Birbes et al., 2001), further supporting a role of
endogenous mitochondrial ceramide in regulating apoptosis.
Materials and methods
Materials
[ -
32P]ATP, [
3H]palmitic acid, and L-3-[
3H]serine were purchased from
Amersham Biosciences. Dihydro-S1P, S1P, FB1, myriocin (ISP-1), sphingo-
sine, and PDMP were obtained from Biomol Research Laboratory Inc. Se-
rum and medium were obtained from Biofluids, Inc. G418 was from Invi-
trogen. Recombinant diacylglycerol kinase was from Calbiochem. mAb
against Myc was from Zymed Laboratories, and anti–mouse Texas red–
conjugated goat antibody was from Jackson ImmunoResearch Laborato-
ries. Alexa Fluor
®488–phalloidin, MitoTracker green, anti–cytochrome c
oxidase subunit II mAb, polyclonal rabbit anti-calnexin antibody, and the
Anti-Fade kit were from Molecular Probes. Anti–protein disulfide
isomerase (PDI) was from StressGen Biotechnologies. Other chemicals
were from Sigma-Aldrich.
Cell culture
NIH 3T3 fibroblasts (American Type Culture Collection [ATCC] accession
No. CRL-1658) and human embryonic kidney cells (HEK 293; ATCC CRL-
1573) were cultured in high glucose DME containing 100 U/ml penicillin,
100  g/ml streptomycin, and 2 mM L-glutamine supplemented with 10%1048 The Journal of Cell Biology | Volume 158, Number 6, 2002
calf serum or FBS, respectively (Olivera et al., 1999). Cells were transfected
with Myc-pcDNA3 alone or with Myc-pcDNA3 containing mSPP-1 con-
struct using Lipofectamine Plus (Life Technologies) as previously described
(Mandala et al., 2000). Transfection efficiencies were typically 30% and
60% for NIH 3T3 and HEK 293 cells, respectively. Stable transfectants of
HEK 293 cells were selected in medium containing 1 g/liter G418.
S1P phosphohydrolase activity
HEK 293 cells (2   10
6) were seeded in 100-mm poly-D-lysine–coated
plates and cultured to confluency. Cells were washed twice with ice-cold
PBS and scraped on ice with 1 ml of buffer A (100 mM Hepes, pH 7.5, con-
taining 10 mM EDTA, 1 mM DTT, and 10  g/ml each leupeptin, aprotinin,
and soybean trypsin inhibitor). Cells were freeze–thawed seven times and
then centrifuged at 100,000 g for 1 h. Crude membranes were resuspended
in buffer A and protein concentrations were determined by the Bradford as-
say (Bio-Rad Laboratories). 
32P-labeled S1P was prepared with recombinant
SPKH1a as previously described (Olivera et al., 2000). mSPP-1 activity was
determined by adding 
32P-labeled S1P (2 nmol, 100,000 cpm, 0.3% BSA
complex) to membrane fractions (4  g) in 200  l buffer A, and S1P phos-
phohydrolase activity was determined as recently described (Le Stunff et al.,
2002). Similar results were obtained by measurement of disappearance of
labeled S1P or by formation of sphingosine (Le Stunff et al., 2002). Where
indicated, 
32P-labeled dihydro-S1P was used as substrate.
Immunofluorescence and confocal microscopy
Vector or Myc–SPP-1 transfectants grown on glass coverslips coated with
collagen I were incubated overnight in DME supplemented with 2  g/ml
insulin, 2  g/ml transferrin, and 20  g/ml BSA. Cells were washed with
PBS, fixed for 20 min at room temperature with 4% paraformaldehyde in
5% sucrose, and permeabilized with 0.1% Triton X-100 in PBS for 5 min.
After washing, cells were incubated for 45 min with primary antibodies for
Myc and calnexin in PBS containing 0.1% BSA, and then for 45 min with
the corresponding secondary antibodies conjugated with Texas red. In
some experiments, Alexa Fluor
®488 fluorescent phalloidin or Texas red
WGA were also included in the secondary antibody incubation. To visual-
ize mitochondria, cells were incubated with 500 nM MitoTracker green for
30 min at 37 C before fixation. Coverslips were mounted on glass slides
using an Anti-Fade kit and examined by confocal microscopy. Images
were collected by an Olympus Fluoview laser scanning microscope
equipped with argon (488 nm) and krypton (568 nm and 647 nm) lasers
and a 60X/1.4 NA PlanApo lens. Quantitative image analysis was per-
formed using Metamorph image processing software. To avoid fluores-
cence crossover between the channels, FITC and Texas red images were
collected separately using the appropriate laser excitation (488 nm and
568 nm, respectively) and then merged.
Subcellular fractionation
HEK 293 cells overexpressing Myc-tagged mSPP-1 were rinsed twice in
ice-cold PBS, resuspended in buffer A containing 0.25 M sucrose, and ho-
mogenized in a Dounce homogenizer at 4 C. Subcellular fractionation
was performed by sequential centrifugation: lysates were centrifuged at
1,000 g for 5 min at 4 C to remove unbroken cells and nuclei, postnuclear
supernatants were further centrifuged for 15 min at 17,000 g at 4 C, and
the pellet P1 (intracellular membrane fraction containing mitochondria,
ER, and Golgi) was resuspended in the same buffer. The remaining super-
natant was centrifuged at 100,000 g for 1 h at 4 C to obtain cytosol and
pellet P2 containing the plasma membranes.
Western blot analysis
Equal amounts of protein were separated on 7.5 or 10% SDS-PAGE and
electroblotted onto nitrocellulose membranes for 1 h at 100 V and 4 C.
Blots were blocked in 5% nonfat dry milk in TBS containing 0.1% Tween-
20 (TBST) for 2 h at room temperature and probed with anti-Myc mAb or
with anti–cytochrome oxidase II, anti-PDI, or anti– v-integrin antibodies as
markers for mitochondria, ER, and plasma membrane, respectively. After
washing three times with TBST, blots were incubated with secondary anti-
bodies for 1 h at room temperature. Protein bands were visualized by ECL
using Super Signal (Pierce Chemical Co.).
Measurement of mass levels of sphingosine and ceramide
HEK 293 cells (5   10
5) were seeded in six-well poly-L-lysine–coated
plates. Cells were incubated with 5  M S1P or dihydro-S1P for the indi-
cated time periods. Mass levels of sphingosine and ceramide and total
phospholipids in cellular lipid extracts were measured essentially as previ-
ously described (Edsall et al., 1997).
Labeling with L-3-[
3H]serine and [
3H]palmitic acid
Vector- or mSPP-1–transfected HEK 293 cells were incubated without or
with 5  M S1P or dihydro-S1P in the absence or presence of [
3H]palmitic
acid (10  Ci/ml) or L-3-[
3H]serine (30  Ci/ml). 24 h later, cells were
scraped twice in 600  l of methanol/concentrated HCl (200:2). Extracts
were sonicated and 600  l of chloroform and 500  l of H2O were added,
mixed, and phases were separated by the addition of 600  l 2 M KCL and
600  l chloroform and vigorous vortexing. Aliquots of the organic phases
(corresponding to 5   10
6 cpm) were spotted on silica gel plates and de-
veloped in chloroform/acetic acid (9:1). Labeled sphingolipids were visu-
alized by autoradiography and [
3H]ceramide was quantified by a radio-
chromatogram scanner (Bioscan).
Staining of apoptotic nuclei
Apoptosis was assessed by staining cells with 8  g/ml bisbenzimide trihy-
drochloride (Hoechst 33258) in 30% glycerol/PBS for 10 min at room tem-
perature. The percentage of apoptotic cells, distinguished by condensed,
fragmented nuclear regions, was determined as previously described (Ol-
ivera et al., 1999). A minimum of 500 cells were scored in a double
blinded manner.
Reproducibility of data
Experiments were repeated at least three times with consistent results and
statistical differences were determined by ANOVA. Statistically different
groups are indicated by an asterisk (P   0.05).
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